electroCore appoints Dr. Charles Theofilos to Board; board expands to eight members

electroCore, Inc.

Dr. Theofilos appointed as Class III director effective Dec. 8, 2023; board size increased from 7 to 8.
Theofilos is a retired neurosurgeon and founder of several healthcare companies, including a predecessor to electroCore.
He will receive standard non-employee director compensation and an inaugural equity grant effective Jan. 1, 2024.
His spouse's entity, Happy Holstein Management, participated in the Company's August 2023 registered direct offering and private placement.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Charles S. Theofilos

Director

ECOR · electroCore, Inc.

Effective: 2023-12-08
Filed: December 14, 2023, 6:59 PM ET

On December 8, 2023, the board of directors (the “ Board ”) of electroCore, Inc. (the “ Company ”) appointed Charles S. Theofilos, M.D., as a new Class III member of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Charles S. Theofilos was appointed as Director at electroCore, Inc..

Action: appointed
Role: Director

Exact text from the filing

On December 8, 2023, the board of directors (the “ Board ”) of electroCore, Inc. (the “ Company ”) appointed Charles S. Theofilos, M.D., as a new Class III member of the Board.

View on SEC.gov

electroCore, Inc. filing history →

Source: SEC EDGAR

accession 0001193805-23-001596

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.